Homepage
Open in app
Sign in
Get started
ZS
Impact where it matters.
Follow
The evolving Alzheimer’s landscape: Unmet needs and implications for pharma and biotech
The evolving Alzheimer’s landscape: Unmet needs and implications for pharma and biotech
The Alzheimer’s landscape is in a state of flux, marked by both progress and persistent challenges, learn more.
Yasasvi Popuri
Jun 17
Winning in the APAC private vaccines market
Winning in the APAC private vaccines market
Overall, understanding the ecosystem of players and their strategic considerations is key to winning in the private vaccine market in APAC.
Adi Natu
Jun 14
Building a robust data stewardship tool
Building a robust data stewardship tool
Learn about a new tool within the Databricks environment leveraging Databricks widgets and Python hypertext markup language (HTML) tags.
Abhinav Batra
Jun 14
The European Accessibility Act: Implications for US healthcare
The European Accessibility Act: Implications for US healthcare
Learn about how EAA compliance will be challenging for many organizations, especially those that have not prioritized accessibility.
Stephanie Bach
Jun 12
Oncology vertical goes to PMSA
Oncology vertical goes to PMSA
Deepika Sinha and Jeevan Elanchelvan, leaders in the oncology vertical at ZS, attended the PMSA Conference. Read their key takeaways.
Jeevarasan Elanchelvan
Jun 2
CMS sales and marketing rules and implications for AEP 2025: Navigating changes in how agents are…
CMS sales and marketing rules and implications for AEP 2025: Navigating changes in how agents are…
The Centers for Medicare & Medicaid Services (CMS) has recently adjusted several rules impacting agent and broker compensation.
Daniel Galajda
May 29
Designing for the ACNU consumer experience
Designing for the ACNU consumer experience
Learn about the importance of the consumer experience (CX) in ACNU.
Dan Frey
May 24
The business of beauty: The evolving med spa landscape and opportunities for manufacturers
The business of beauty: The evolving med spa landscape and opportunities for manufacturers
The med spa revolution is well underway, and those manufacturers who can rise to the occasion will be poised to thrive.
Yasasvi Popuri
May 24
Pharma DTC marketing 2.0 is digital health
Pharma DTC marketing 2.0 is digital health
Pharmaceutical companies must embrace digital health solutions as a powerful wraparound to their marketing efforts.
Vijesh Unnikrishnan
May 24
From data to decisions: Leveraging Generative AI and data products
From data to decisions: Leveraging Generative AI and data products
Abhinav Batra and I were invited to speak at the Pharma SOS Conference. Learn more about our favorite topics, data products and Gen AI.
Willem Koenders
May 15
Break down how your customers make decisions with strategies that enable the elusive goal: N=1…
Break down how your customers make decisions with strategies that enable the elusive goal: N=1…
ZS is offering a new approach to achieve every marketer’s dream — nano-segmentation to support omnichannel planning and execution.
Adnan Patel
May 15
AI partnerships in medtech: A cause for cautious optimism
AI partnerships in medtech: A cause for cautious optimism
Learn about the promise and challenges about AI partnerships in medtech.
Bhargav Mantha
Apr 25
Pushing the generics button on the biosimilars contracting
Pushing the generics button on the biosimilars contracting
Unpacking alliances between biosimilar manufacturers and payers: A deep dive by ZS’s Biosimilars CoE
Prateek Yadav
Apr 13
Early-stage funding opportunities in Singapore: An interview with Guy Heathers Albatroz…
Early-stage funding opportunities in Singapore: An interview with Guy Heathers Albatroz…
The first step is the hardest: In the dynamic world of biotechnology, the journey begins with securing early-stage funding.
Mei Chee Lim
Apr 12
About ZS Associates
Latest Stories
Archive
About Medium
Terms
Privacy
Teams